Clinical trial
Trial to Investigate the Efficacy of Olmesartan in Paroxysmal Atrial…
NCT00098137 · Atrial Fibrillation Network, Other · Completed
Key facts
| NCT number | NCT00098137 |
|---|---|
| Title | Trial to Investigate the Efficacy of Olmesartan in Paroxysmal Atrial Fibrillation |
| Official title | Angiotensin II-Antagonist in Paroxysmal Atrial Fibrillation Trial (ANTIPAF Trial) |
| Lead sponsor | Atrial Fibrillation Network, Other |
| Collaborators | Daiichi Sankyo Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Heart Disease, Arrhythmia, Atrial Fibrillation |
| Intervention type | Drug |
| Interventions | Olmesartan |
| Enrollment | 422 |
| Start date | Jan 1, 2005 |
| Primary completion | May 1, 2009 |
| Completion | May 1, 2009 |
| First posted | Dec 6, 2004 |
| Last update posted | Sep 11, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: